Related Experiment Video
Updated: May 7, 2026
07:57
An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices
Published on: April 11, 2018
6.6K
A new PERKspective on neurodegeneration.
Wiep Scheper1, Jeroen J M Hoozemans
1Department of Clinical Genetics and Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands.
Science Translational Medicine
|October 11, 2013
Summary
Targeting stress-induced kinases that regulate protein synthesis offers a promising therapeutic avenue for neurodegenerative diseases. This approach focuses on modulating cellular stress responses to potentially halt disease progression.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Neurodegenerative diseases are characterized by progressive neuronal dysfunction and loss.
- Cellular stress pathways, including those involving kinases, are increasingly implicated in disease pathogenesis.
- Protein synthesis dysregulation is a common feature in various neurodegenerative conditions.
Purpose of the Study:
- To explore the therapeutic potential of targeting stress-induced kinases.
- To investigate the role of kinases regulating protein synthesis in neurodegeneration.
- To identify novel therapeutic strategies for neurodegenerative disorders.
Main Methods:
- Investigated stress-induced kinases involved in protein synthesis regulation.
- Utilized cellular and/or animal models of neurodegenerative diseases.
- Assessed the impact of kinase modulation on neuronal health and protein synthesis.
Main Results:
- Identified specific stress-induced kinases that critically regulate protein synthesis.
- Demonstrated that modulating these kinases affects disease progression in models.
- Showcased a potential link between kinase activity, protein synthesis, and neuronal survival.
Conclusions:
- Targeting stress-induced kinases regulating protein synthesis represents a viable therapeutic strategy.
- This approach may offer a novel treatment paradigm for neurodegenerative diseases.
- Further research is warranted to translate these findings into clinical applications.
Related Concept Videos
01:15Neurogenesis and Regeneration of Nervous Tissue
2.1K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
2.1K
01:23Alzheimer Disease ll: Pathophysiology
44
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
44
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:29Alzheimer Disease l: Introduction
38
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34